At a Glance
- Tasks: Lead the development of innovative biomarker strategies for late-stage oncology clinical trials.
- Company: Join a pioneering pharmaceutical company focused on transforming cancer treatment.
- Benefits: Competitive salary, bonuses, health insurance, retirement plans, and generous leave policies.
- Other info: Collaborative environment with opportunities for professional growth and scientific contributions.
- Why this job: Make a real difference in oncology by driving cutting-edge research and patient-focused strategies.
- Qualifications: PhD or medical degree with 5+ years in oncology biomarkers and clinical development.
The predicted salary is between 80000 - 100000 £ per year.
In this role, you will be responsible for the development and effective implementation of biomarker and translational medicine strategies to support the clinical development of late-stage oncology assets. As a key member of a Clinical Matrix Team (CMT), the Clinical Biomarker Director will collaborate with the Clinical Biomarker Executive Director to establish clear decision‑making criteria, define patient segmentation strategies, and integrate these into clinical development plans. You will leverage cutting‑edge technologies and methodologies to discover and clinically validate biomarkers, ensuring the biomarker strategy is fully aligned with the clinical plan. This integration will optimise decision‑making in drug development and enable the identification of the right patient populations for our medicines.
Responsibilities
- Collaborate closely with the Clinical Biomarker Executive Director to drive the design, alignment, and execution of clinical biomarker and translational medicine strategies focused on identifying predictive biomarkers that enable clinical success.
- Validate and implement biomarker strategies, including target engagement, pharmacodynamic, and proof‑of‑mechanism biomarkers, for clinical‑phase programs to support patient stratification, dose selection, and enable clinical go/no‑go decisions.
- Participate in tumor‑specific Biomarker Matrix teams, with responsibility for executing clinical biomarker strategies for late‑stage oncology programs, while working closely with internal and external stakeholders, as well as disease area strategy teams.
- Represent Translational Medicine at Clinical Development Matrix Teams (CMT) to establish biomarker‑driven decision‑making criteria and their seamless integration into clinical study designs, aligning with clinical study objectives.
- Identify cutting‑edge science and technological advances to incorporate into biomarker strategies for guiding indication selection, patient enrichment, and combination strategies.
- Oversee and/or develop sample testing plans and deliver high‑quality biomarker data packages to inform clinical development and regulatory strategies.
- Manage effective relationships with clinical and scientific operations, diagnostics, medical science, medical affairs, regulatory, portfolio management, and commercial functions.
- Support the expansion of mechanism and disease understanding to generate insights for indication expansion and scientific exchange as needed.
- Contribute to the company’s scientific credibility through publications and presentations.
Basic Qualifications
- PhD in Life Sciences or Medical degree.
- Minimum of 5 years of experience in the pharmaceutical industry, with a solid background in oncology clinical biomarkers—expertise in late‑phase oncology studies—and translational research within clinical development.
- Experience in leading cross‑functional teams and executing strategic biomarker plans.
- Experience in conducting clinical trials and working as part of clinical study teams.
- Expertise in interpreting clinical biomarker data and evaluating innovative biomarker technologies for clinical trial applications.
- Experience in influencing teams and key leaders.
Preferred Qualifications
- Experience with high‑dimensional dataset analysis.
- Expertise in identifying predictive biomarkers and/or diagnostic development.
- Excellent communication, problem‑solving, and presentation skills.
- Strong interpersonal skills and ability to thrive in a team‑oriented environment.
Compensation and Benefits
If you are based in Cambridge, MA; Waltham, MA; Rockville, MD; or San Francisco, CA, the annual base salary for new hires in this position ranges $189,750 to $316,250. The US salary ranges take into account a number of factors including work location within the US market, the candidate’s skills, experience, education level and the market rate for the role. In addition, this position offers an annual bonus and eligibility to participate in our share‑based long‑term incentive program which is dependent on the level of the role. Available benefits include health care and other insurance benefits (for employee and family), retirement benefits, paid holidays, vacation, and paid caregiver/parental and medical leave.
We are an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law.
Director, Oncology Clinical Biomarkers employer: Council of State and Territorial Epidemiologists
As a leading employer in the pharmaceutical industry, we offer an innovative and collaborative work environment that empowers our employees to drive impactful oncology research. Located in vibrant hubs like Cambridge and San Francisco, we provide competitive salaries, comprehensive benefits, and ample opportunities for professional growth, ensuring that our team members thrive both personally and professionally while contributing to groundbreaking advancements in patient care.
Contact Details:
Council of State and Territorial Epidemiologists Recruitment Team